EUVIMEDEUVIMED entdecken
Crossref

Unveiling the miR‑26a‑5p/MSMO1/7‑DHC Axis: A Novel Therapeutic Target in Myocardial Ischemia-Reperfusion Injury

Yonglin Fu, Bingjie Han, Jiankai Zhang, Lu Liu, Wenjie Chen, Ciying Kuang, Mei Jiang, Xiaojun Cui

Cardiovascular Drugs and Therapy · 2026-12 · 40 (6) · 2241-2259

DOI: 10.1007/s10557-026-07922-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 10.08.2026. Verfasst von Yonglin Fu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Dongguan Key Laboratory of Stem Cell and Regenerative Tissue Engineering, Guangdong Medical University, Dongguan, 5…. Hauptthemen laut MEDLINE: MicroRNAs, Myocardial Reperfusion Injury, Ferroptosis, Mixed Function Oxygenases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: the General Program of the Natural Science Foundation of Xinjiang Uygur Autonomous Region, the Characteristic Innovation Project of Ordinary Universities in Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis plays a critical role in myocardial ischemia-reperfusion injury (MIRI). Here, we discovered that MSMO1, a key enzyme in the cholesterol biosynthesis pathway, regulates ferroptosis in MIRI, and identified miR-26a-5p as an upstream regulator of MSMO1. During MIRI, downregulation of miR-26a-5p led to suppression of MSMO1, reduction of 7-DHC accumulation, and promotion of lipid peroxidation and ferroptosis. To translate this mechanism, we developed engineered exosomes delivering miR-26a-5p. In cellular and mouse MIRI models, this intervention significantly attenuated serum levels of cardiac injury biomarkers (cTnI and CK-MB), restored systemic antioxidant capacity, and attenuated early myocardial fibrosis. This work provides a novel therapeutic strategy for MIRI and provides preclinical evidence supporting the potential of engineered exosomes as a cell-free therapeutic platform.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMyocardial Reperfusion InjuryFerroptosisMixed Function OxygenasesMyocytes, CardiacAnimalsExosomesMice, Inbred C57BLMaleMiceHumansDisease Models, AnimalLipid PeroxidationFibrosisSignal Transduction

Stichwörter der Autor:innen

7-DHCEngineered exosomesFerroptosisMSMO1MiR-26a-5pMyocardial ischemia-reperfusion injury

Substanzen

MicroRNAsMirn26 microRNA, mouseMixed Function Oxygenases

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Dongguan Key Laboratory of Stem Cell and Regenerative Tissue Engineering, Guangdong Medical University, Dongguan, 523808, China.
  • School of Medicine, Kashi University, Kashi, 844000, China.
  • School of Basic Medical Sciences, Dongguan Key Laboratory of Stem Cell and Regenerative Tissue Engineering, Guangdong Medical University, Dongguan, 523808, China. jiangm528@gdmu.edu.cn.
  • School of Basic Medical Sciences, Dongguan Key Laboratory of Stem Cell and Regenerative Tissue Engineering, Guangdong Medical University, Dongguan, 523808, China. cuixiaojun@gdmu.edu.cn.
  • School of Medicine, Kashi University, Kashi, 844000, China. cuixiaojun@gdmu.edu.cn.

Förderung

  • the General Program of the Natural Science Foundation of Xinjiang Uygur Autonomous Region
  • the Characteristic Innovation Project of Ordinary Universities in Guangdong Province

Zitieren

APA

Fu, Y., Han, B., Zhang, J., Liu, L., Chen, W., Kuang, C., Jiang, M., & Cui, X. (2026). Unveiling the miR‑26a‑5p/MSMO1/7‑DHC Axis: A Novel Therapeutic Target in Myocardial Ischemia-Reperfusion Injury. Cardiovascular Drugs and Therapy, 40(6), 2241-2259. https://doi.org/10.1007/s10557-026-07922-2

Vancouver

Fu Y, Han B, Zhang J, Liu L, Chen W, Kuang C, et al. Unveiling the miR‑26a‑5p/MSMO1/7‑DHC Axis: A Novel Therapeutic Target in Myocardial Ischemia-Reperfusion Injury. Cardiovascular Drugs and Therapy. 2026;40(6):2241-2259. doi:10.1007/s10557-026-07922-2

BibTeX
@article{Fu2026,
  author = {Fu, Yonglin and Han, Bingjie and Zhang, Jiankai and Liu, Lu and Chen, Wenjie and Kuang, Ciying and Jiang, Mei and Cui, Xiaojun},
  title = {Unveiling the miR‑26a‑5p/MSMO1/7‑DHC Axis: A Novel Therapeutic Target in Myocardial Ischemia-Reperfusion Injury},
  journal = {Cardiovascular Drugs and Therapy},
  year = {2026},
  volume = {40},
  number = {6},
  pages = {2241--2259},
  doi = {10.1007/s10557-026-07922-2}
}
Kostenlos starten →